|
| Status |
Public on Mar 24, 2011 |
| Title |
Phosphorylation of p53 Serine 46 contributes to target gene selectivity of p53 (ChIP-seq) |
| Organism |
Homo sapiens |
| Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
The tumor suppressor p53 plays a crucial role in cellular growth control inducing a plethora of cellular response pathways. The molecular mechanisms that discriminate between the distinct p53-responses towards different stress treatments have remained largely elusive. Here, we have analyzed the p53-regulated pathways induced by two chemotherapeutical treatments, Actinomycin D inducing growth arrest and Etoposide resulting in apoptosis. We found that the genome-wide p53-binding patterns are almost identical upon both treatments notwithstanding transcriptional differences that we observed in genome-wide transcriptome analysis. To assess the role of post-translational modifications in target gene choice and activation we investigated the extent of phosphorylation of Serine 46 of p53 bound to DNA (p53-pS46), a modification that has been linked to apoptosis-pathways, and the extent of phosphorylation of Serine 15 (p53-pS15), a general p53-activation mark. Interestingly, the overall extent of S46 phosphorylation of p53 bound to DNA is considerably higher in cells directed towards apoptosis while the degree of phosphorylation at S15 of DNA bound p53 remains highly similar upon both treatments. Moreover, our data suggest that, following different chemotherapeutical treatments, the extent of chromatin-associated p53 phosphorylated at S46 but not at pS15 is higher on certain apoptosis related target genes, including the BAX and PUMA genes. These data provide evidence that cell fate decisions are not made primarily on the level of general p53 DNA-binding, but possibly through post-translational modifications of chromatin bound p53.
|
| |
|
| Overall design |
ChIP-seq profiles of p53, p53phosphorylated at Serine 15 (p53-pS15) and p53 phosphorylated at Serine 46 (p53-pS46) in U2OS cells treated with either Actinomycin D or Etoposide.
|
| |
|
| Contributor(s) |
Smeenk L, van Heeringen SJ, Koeppel M, Janssen-Megens EM, Stunnenberg HG, Lohrum M |
| Citation(s) |
21394211 |
| Submission date |
May 20, 2010 |
| Last update date |
May 15, 2019 |
| Contact name |
Marion Lohrum |
| E-mail(s) |
Lohrum@em.uni-frankfurt.de
|
| Phone |
+31 24 3610541
|
| Fax |
+31 24 3610520
|
| URL |
http://www.ncmls.nl/NCMLS/MenuStructures/PI/theme3/MarionLohrum.asp
|
| Organization name |
NCMLS
|
| Department |
Molecular Biology
|
| Street address |
P.O. Box 9101
|
| City |
Nijmegen |
| ZIP/Postal code |
6500 HB |
| Country |
Netherlands |
| |
|
| Platforms (1) |
| GPL9052 |
Illumina Genome Analyzer (Homo sapiens) |
|
| Samples (6)
|
|
| This SubSeries is part of SuperSeries: |
| GSE22186 |
Phosphorylation of p53 Serine 46 contributes to target gene selectivity of p53 |
|
| Relations |
| SRA |
SRP002486 |
| BioProject |
PRJNA129399 |
Less...
More...